Ibogaine research advances as Trump signs executive order
President Trump signed an executive order to ease federal restrictions on the psychedelic ibogaine and announced $50 million in federal research funding. The FDA said it will begin steps to allow human trials and add three psychedelics to a priority review pilot program.
